Juan Pablo Rigalli
- Oncology top 10%
- Molecular Biology
- Pharmacology top 5%
- Cancer Research
- Surgery
- Co-authors
- María Laura RuizViviana A. CataniaSilvina Stella Maris VillanuevaAldo D. MottinoJohanna WeißJoost G.J. HoenderopMarcelo G. LuquitaMaría Paula Ceballos
- Topics
- Drug Transport and Resistance Mechanisms (34 papers)Extracellular vesicles in disease (9 papers)Pharmacological Effects and Toxicity Studies (9 papers)
- Cited by
- PharmacologyOncologyCancer Research
- Partner nations
- ArgentinaGermanyNetherlands
In The Last Decade
Juan Pablo Rigalli
52 papers receiving 885 citations
Peers
Comparison fields: 5 of 93
- Oncology 390
- Molecular Biology 369
- Pharmacology 136
- Cancer Research 113
- Surgery 100
Countries citing papers authored by Juan Pablo Rigalli
This map shows the geographic impact of Juan Pablo Rigalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Pablo Rigalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Pablo Rigalli more than expected).
Fields of papers citing papers by Juan Pablo Rigalli
This network shows the impact of papers produced by Juan Pablo Rigalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Pablo Rigalli. The network helps show where Juan Pablo Rigalli may publish in the future.
Co-authorship network of co-authors of Juan Pablo Rigalli
This figure shows the co-authorship network connecting the top 25 collaborators of Juan Pablo Rigalli. A scholar is included among the top collaborators of Juan Pablo Rigalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Pablo Rigalli. Juan Pablo Rigalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 15 | |
| 7 | 12 | |
| 8 | 16 | |
| 9 | 10 | |
| 10 | 15 | |
| 11 | 9 | |
| 12 | 20 | |
| 13 | 23 | |
| 14 | 19 | |
| 15 | 57 | |
| 16 | 8 | |
| 17 | 17 | |
| 18 | 17 | |
| 19 | 47 | |
| 20 | 16 |
About Juan Pablo Rigalli
Juan Pablo Rigalli is a scholar working on Oncology, Pharmacology and Physiology, having authored 52 papers that have together received 891 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (34 papers), Extracellular vesicles in disease (9 papers) and Pharmacological Effects and Toxicity Studies (9 papers). The work is most often cited by research in Pharmacology (136 citations), Oncology (390 citations) and Cancer Research (113 citations). Juan Pablo Rigalli has collaborated with scholars based in Argentina, Germany and Netherlands. Frequent co-authors include María Laura Ruiz, Viviana A. Catania, Silvina Stella Maris Villanueva, Aldo D. Mottino, Johanna Weiß, Joost G.J. Hoenderop, Marcelo G. Luquita, María Paula Ceballos, Eric Barros and Dirk Theile. Their work appears in journals such as PLoS ONE, The FASEB Journal and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.